Advertisement

Association of genetic variations in the vitamin D pathway with susceptibility to tuberculosis in Kazakhstan

  • Mukhtar Sadykov
  • Azliyati Azizan
  • Ulan KozhamkulovEmail author
  • Ainur Akilzhanova
  • Dauren Yerezhepov
  • Max Salfinger
  • Chee Kai ChanEmail author
Original Article

Abstract

Tuberculosis (TB) poses an important health challenge and a significant economic burden for Kazakhstan and in Central Asia. Recent findings show a number of immunological related processes and host Mycobacterium tuberculosis defense are impacted by a variety of genes of the human host including those that play a part in the vitamin D metabolism. We investigated the genetic variation of genes in the vitamin D metabolic pathway of a cohort 50 TB cases in Kazakhstan and compared them to 34 controls living in the same household with someone infected with TB. We specifically analyzed 11 SNPs belonging to the following genes: DHCR7, CYP2R1, GC-1, CYP24A1, CYP27A1, CYP27B1, VDR and TNFα. These genes play a number of different roles including synthesis, activation, delivery and binding of the activated vitamin D. Our preliminary results indicate significant association of VDR (vitamin D receptor) SNPs (rs1544410, BsmI, with OR = 0.425, CI 0.221–0.816, p = 0.009 and rs731236, TaqI with OR = 0.443, CI 0.228–0.859, p = 0.015) and CYP24A1 (rs6013897 with OR = 0.436, CI 0.191–0.996, p = 0.045) with TB. Interaction of genetic variation of VDR and CYP24A1 may impact susceptibility to TB. The findings provided initial clues to understand individual genetic differences in relation to susceptibility and protection to TB.

Keywords

Tuberculosis SNP VDR Kazakhstan Vitamin D 

Notes

Acknowledgements

We like to acknowledge that the SNP genotyping was done with the support and the use of the SNP array developed by Fitgenes Pty Ltd, Melbourne Australia. We are grateful to Columbia University Global Health Research Center of Central Asia, Almaty and National TB Center, Almaty for organizational support of study participant recruitment.

Author contributions

CKC, AAk, MS, AAz, UK conceptualized, design and coordinated the investigation. MS analyzed the data and carried out the statistical analysis. DY, AAk, UK participated in sample collection and DNA extraction. All authors participated in writing, reading and approval of the final manuscript.

Funding

This work was supported by the Nazarbayev University School of Medicine Social Policy Grant 2016 and by the Ministry of Education and Science of the Republic of Kazakhstan (Grants No. AP05134737, 0111RK00442).

Compliance with ethical standards

Conflict of interest

The authors declare that there no conflict of interest. Author CKC has minimal shares in Fitgenes Pte Ltd. Fitgenes Pte Ltd had no role in the design of the study; in the collection or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of Ethics Committee of Center for Life Sciences, National Laboratory Astana, Kazakhstan. Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Global Tuberculosis Report 2018. World Health Organization, Geneva; 2018. Licence: CC BY-NC-SA 3.0 IGOGoogle Scholar
  2. 2.
    Adenov M (2018) Statistic TB reviews. Ministry of Health Republic of Kazakhstan, National Scientific Center for Phthisiopulmomology, Almaty (in Russian)Google Scholar
  3. 3.
    Ding F, Kong Y (2015) Host immune factors related to susceptibility to tuberculosis in animal models. J Immun Res 2(1):1014Google Scholar
  4. 4.
    Silva-Ramírez B, Saenz-Saenz CA, Bracho-Vela LA et al (2019) Association between vitamin D receptor gene polymorphisms and pulmonary tuberculosis in a Mexican population. Indian J Tuberc 66:70–75.  https://doi.org/10.1016/j.ijtb.2018.04.005 CrossRefPubMedGoogle Scholar
  5. 5.
    Azad AK, Sadee W, Schlesinger LS (2012) Innate immune gene polymorphisms in tuberculosis. Infect Immun 80:3343–3359CrossRefGoogle Scholar
  6. 6.
    Fol M, Druszczynska M, Wlodarczyk M, Ograczyk E, Rudnicka W (2015) Immune response gene polymorphisms in tuberculosis. Acta Biochim Pol 62(4):633–640CrossRefGoogle Scholar
  7. 7.
    Wang Y, Li H-j (2019) A meta-analysis on associations between vitamin D receptor genetic variants and tuberculosis. Microb Pathog 130:59–64.  https://doi.org/10.1016/j.micpath.2019.02.027 CrossRefPubMedGoogle Scholar
  8. 8.
    Garra AO', Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP (2013) The immune response in tuberculosis. Annu Rev Immunol 31:475–527CrossRefGoogle Scholar
  9. 9.
    Cai L, Li Zh, Guan X, Cai K, Wang L, Liu J, Tong Y (2019) The research progress of host genes and tuberculosis susceptibility. Oxid Med Cell Longev.  https://doi.org/10.1155/2019/9273056 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mohammadi A, Khanbabaei H, Nasiri-Kalmarzi R et al (2019) Vitamin D receptor ApaI (rs7975232), BsmI (rs1544410), Fok1 (rs2228570), and TaqI (rs731236) gene polymorphisms and susceptibility to pulmonary tuberculosis in an Iranian population: a systematic review and meta-analysis. J Microbiol Immunol Infect.  https://doi.org/10.1016/j.jmii.2019.08.011 CrossRefPubMedGoogle Scholar
  11. 11.
    Sassi F, Tamone C, D'Amelio P (2018) Vitamin D: nutrient, hormone, and immunomodulator. Nutrients 10(11):1656.  https://doi.org/10.3390/nu10111656 CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Kim EW, Teles RMB, Haile S, Liu PT, Modlin RL (2018) Vitamin D status contributes to the antimicrobial activity of macrophages against Mycobacterium leprae. PLoS Negl Trop Dis 12(7):e0006608.  https://doi.org/10.1371/journal.pntd.0006608 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Haussler MR, Haussler CA, Bartik L et al (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66(10 Suppl 2):98–112.  https://doi.org/10.1111/j.1753-4887.2008.00093.x CrossRefGoogle Scholar
  14. 14.
    Vanherwegen AS, Gysemans C, Mathieu C (2017) Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin N Am 46:1061–1094.  https://doi.org/10.1016/j.ecl.2017.07.010 CrossRefGoogle Scholar
  15. 15.
    Martineau AR, Leandro ACC, Anderson ST et al (2010) Association between GC genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 35(5):1106–1112CrossRefGoogle Scholar
  16. 16.
    Junaid K, Rehman A, Jolliffe DA, Wood K, Martineau AR (2016) Vitamin D deficiency associates with susceptibility to tuberculosis in Pakistan, but polymorphisms in VDR, DBP and CYP2R1 do not. BMC Pulm Med 16:73.  https://doi.org/10.1186/s12890-016-0240-2 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689–1696.  https://doi.org/10.1093/ajcn/80.6.1689S CrossRefGoogle Scholar
  18. 18.
    Davis A, Terlikbayeva A, Aifah A et al (2017) Risks for tuberculosis in Kazakhstan: implications for prevention. Int J Tuberc Lung Dis 21(1):86–92.  https://doi.org/10.5588/ijtld.15.0838 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Hermosilla S, You P, Aifah A et al (2017) Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan. PLoS ONE 12(3):e0172942.  https://doi.org/10.1371/journal.pone.0172942 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Guidelines on tuberculosis control in Republic of Kazakhstan (2008) Ministry of Health Republic of Kazakhstan. National TB Center, Almaty (in Kazakh, Russian)Google Scholar
  21. 21.
    Junaid K, Rehman A (2019) Impact of vitamin D on infectious disease-tuberculosis—a review. Clin Nutr Exp 25:1–10.  https://doi.org/10.1016/j.yclnex.2019.02.003 CrossRefGoogle Scholar
  22. 22.
    Yang BF, Han CL (2006) Meta-analysis of relationship of vitamin D receptor polymorphism and tuberculosis. China Trop Med 6:1347–1349 (in Chinese) Google Scholar
  23. 23.
    Gao L, Tao Y, Zhang L, Jin Q (2010) Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 14(1):15–23PubMedGoogle Scholar
  24. 24.
    Panda S, Tiwari A, Luthra K et al (2019) Association of Fok1 VDR polymorphism with vitamin D and its associated molecules in pulmonary tuberculosis patients and their household contacts. Sci Rep 9:15251.  https://doi.org/10.1038/s41598-019-51803-8 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Nnoaham KE, Clarke A (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37:113–119.  https://doi.org/10.1093/ije/dym247 CrossRefPubMedGoogle Scholar
  26. 26.
    Arnedo-Pena A, Juan-Cerdan JV, Romeu-Garcia MA et al (2015) Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study. Epidemiol Infect 143:1731–1741CrossRefGoogle Scholar
  27. 27.
    Gurjav U, Ankhbat M, Ganbaatar G et al (2019) Vitamin D deficiency is associated with tuberculosis infection among household contacts in Ulaanbaatar, Mongolia. Int J Tuberc Lung Dis 23(8):919–923.  https://doi.org/10.5588/ijtld.19.0047 CrossRefPubMedGoogle Scholar
  28. 28.
    Areeshi MY, Mandal RK, Panda AK, Haque S (2014) Vitamin D receptor ApaI gene polymorphism and tuberculosis susceptibility: a meta-analysis. Genet Test Mol Biomark 18(5):323–329.  https://doi.org/10.1089/gtmb.2013.0451 CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2020

Authors and Affiliations

  1. 1.Department of Biomedical Sciences, School of MedicineNazarbayev UniversityNur-SultanKazakhstan
  2. 2.Laboratory of Genomic and Personalized Medicine, National Laboratory AstanaNazarbayev UniversityNur-SultanKazakhstan
  3. 3.University of South Florida College of Public HealthTampaUSA
  4. 4.University of South Florida Morsani College of MedicineTampaUSA

Personalised recommendations